戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 tudied, two of which had a family history of pachyonychia and 11 of which were sporadic cases.
2 RT6 family, such as in KRT6A and KRT6B cause pachyonychia congenita (PC) -1 and -2, respectively.
3 ating lesions that arise in individuals with pachyonychia congenita (PC) and feature upregulation of
4    Palmoplantar keratoderma is a hallmark of pachyonychia congenita (PC) and focal non-epidermolytic
5                                              Pachyonychia congenita (PC) is a dominantly inherited ge
6                                              Pachyonychia congenita (PC) is a genetic disorder of ker
7                                              Pachyonychia congenita (PC) is a group of autosomal domi
8                                              Pachyonychia congenita (PC) is a keratinizing disorder p
9                                              Pachyonychia congenita (PC) is a rare autosomal dominant
10                                              Pachyonychia congenita (PC) is a rare, autosomal dominan
11                                              Pachyonychia congenita (PC) is an autosomal dominant gen
12                                              Pachyonychia congenita (PC) is an autosomal-dominant ker
13 of small interfering RNA (siRNA; TD101) into pachyonychia congenita (PC) patient foot lesions resulte
14 D101) that targets the causative mutation in pachyonychia congenita (PC) patients.
15 ning overlapping phenotypes between FPPK and pachyonychia congenita (PC) will continue because only o
16                       A notable exception is pachyonychia congenita (PC), a disorder in which the nai
17 rtner type II keratin 6 (Krt6a, Krt6b) cause pachyonychia congenita (PC), a disorder typified by dyst
18  altering the coding sequence of KRT16 cause pachyonychia congenita (PC), a rare autosomal dominant d
19 sorders apparented to ectodermal dysplasias, pachyonychia congenita (PC), and steatocystoma multiplex
20  genes, KRT6A, KRT6B, KRT16, or KRT17, cause pachyonychia congenita (PC), characterized by hypertroph
21 onsible for the rare monogenic skin disorder pachyonychia congenita (PC), we demonstrate that small i
22 ytes from Krt16 null mouse skin, a model for pachyonychia congenita (PC)-associated palmoplantar kera
23 arly childhood often suggests a diagnosis of pachyonychia congenita (PC).
24 b clinical trial for the rare skin disorder, pachyonychia congenita (PC).
25 sense mutations at the KRT16 locus can cause pachyonychia congenita (PC, OMIM:167200) or focal non-ep
26 ic siRNAs for epidermolysis bullosa simplex, pachyonychia congenita and Messmann epithelial corneal d
27 By comparison, other hereditary PPKs such as pachyonychia congenita and Olmsted syndrome show prevale
28 expression of the two other genes mutated in pachyonychia congenita diseases, K6 and K16, with that o
29 ndages and directly support the concept that pachyonychia congenita is a disease of the nail bed.
30                                              Pachyonychia congenita is caused by mutations in keratin
31 ited mutations in this gene can cause either pachyonychia congenita or steatocystoma multiplex, the f
32 riven by a patient support organization, the Pachyonychia Congenita Project.
33 etically confirmed PC from the International Pachyonychia Congenita Research Registry who completed a
34                      Given that all forms of pachyonychia congenita show an involvement of the nail,
35 usions: (i) K6a or K16 mutations produce the pachyonychia congenita type 1 phenotype, whereas K17 (or
36                                              Pachyonychia congenita type 2 (PC-2), also known as Jack
37               Epithelial tissues affected in pachyonychia congenita type 2 express the keratin pair K
38                                              Pachyonychia congenita type 2 is an inherited ectodermal
39 although their absence does not preclude the pachyonychia congenita type 2 phenotype.
40 ysts; and (iv) natal teeth are indicative of pachyonychia congenita type 2, although their absence do
41 17 gene (KRT17A) in patients presenting with pachyonychia congenita type 2.
42 notype, whereas K17 (or K6b) mutations cause pachyonychia congenita type 2; (ii) the presence of pilo
43 s following puberty is the best indicator of pachyonychia congenita type 2; (iii) prepubescent patien
44                       Thirteen patients with pachyonychia congenita types 1 and 2 were studied, two o
45 y establishes useful diagnostic criteria for pachyonychia congenita types 1 and 2, which will help li
46 atin 16 (Krt16), one of the genes mutated in pachyonychia congenita, develop pachyonychia congenita-l
47 otype in the type 2 (Jackson-Lawler) form of pachyonychia congenita, previously shown to arise from i
48  feature of dermatoses such as psoriasis and pachyonychia congenita, the currently unclear regulation
49 s mutated in pachyonychia congenita, develop pachyonychia congenita-like PPK.
50 ratoderma (PPK) severely impairs mobility in pachyonychia congenita.
51 e as therapeutic agents for the treatment of pachyonychia congenita.
52 he prevalence and characteristics of itch in pachyonychia congenita.
53 , hyperpigmentation, psoriasis, skin cancer, pachyonychia congenital) caused by aberrant gene express
54 s characterized by early-onset poikiloderma, pachyonychia, hyperkeratosis, bone anomalies and neutrop